Evidence map›Paper›PMID 27995011›Full record

ArticleSpringerPlus2016

Associations of

Xiaohan Shi, Xiaochuan Xie, Xiaoshuang Xun, Yingxian Jia, Shangwei Li

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in SpringerPlus, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xiaohan ShiDivision of Reproductive Medical Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan China ; Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital of Sichuan University, Chengdu, Sichuan China.
Xiaochuan XieDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan China.
Xiaoshuang XunWest China School of Public Health, Sichuan University, Chengdu, Sichuan China.
Yingxian JiaDivision of Reproductive Medical Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan China ; Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital of Sichuan University, Chengdu, Sichuan China.
Shangwei LiDivision of Reproductive Medical Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan China ; Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital of Sichuan University, Chengdu, Sichuan China.
Sichuan University · CNWest China Second University Hospital of Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInterleukin-10 (IL-10) is a powerful modulator of anti-tumor immune responses. The

methodsEligible articles were searched in PubMed, Medline, Embase, Scopus and CNKI up to May 2016. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to detect any potential associations between

resultsA total of 22 case-control studies including 8572 patients and 9843 controls were analyzed. The overall meta-analysis results showed that

conclusionsOur findings suggests that

Indexed as

Genetic polymorphismsInterleukin-10 (IL-10)Meta-analysisUrologic cancer

Identifiers

PMID27995011
PMCPMC5127928
OpenAlexW2559513976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.